SAF
TNXP icon

Smith Anglin Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

Smith Anglin Financial’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$2K – 148
2022
Q1 		– Hold
0
– -$4K – 137
2021
Q4 		– Hold
0
– -$6K – 146
2021
Q3 		– Hold
0
– -$11K – 135
2021
Q2 		– Hold
0
– -$13K – 142
2021
Q1 		– Hold
0
– – – 139